Anticoagulation Trial to Prevent Stroke After Surgery
Phase 4
2,270
about 9.6 years
55+
2 sites in CA, TX
Why this study is shown
What this study is about
Researchers are testing whether a medication can prevent strokes in people who have had atrial fibrillation (AFib) after surgery. The trial will last for 3 years and involve about 2270 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Non-vitamin K oral anticoagulant (NOAC)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Blood Products/Modifiers/Volume Expanders (Unknown Cellular or Molecular Interaction)
oral (Oral Tablet)
Secondary: Incidence of all-cause mortality
Neurology, Cardiology / Heart